Market Cap | 1.25B | P/E | 19.20 | EPS this Y | -24.50% | Ern Qtrly Grth | -39.70% |
Income | 55.08M | Forward P/E | 17.58 | EPS next Y | 8.80% | 50D Avg Chg | 4.00% |
Sales | 875.12M | PEG | 1.01 | EPS past 5Y | -11.82% | 200D Avg Chg | 8.00% |
Dividend | N/A | Price/Book | 2.68 | EPS next 5Y | 15.00% | 52W High Chg | -12.00% |
Recommedations | 3.00 | Quick Ratio | 3.20 | Shares Outstanding | 19.05M | 52W Low Chg | 33.00% |
Insider Own | 41.71% | ROA | 8.54% | Shares Float | 9.95M | Beta | 0.90 |
Inst Own | 55.56% | ROE | 11.23% | Shares Shorted/Prior | 339.54K/292.99K | Price | 64.71 |
Gross Margin | 80.77% | Profit Margin | 6.29% | Avg. Volume | 64,737 | Target Price | 48.00 |
Oper. Margin | 8.38% | Earnings Date | Oct 22 | Volume | 97,838 | Change | 1.25% |
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Fleming John Turman | Director Director | Dec 12 | Sell | 49.7272 | 312 | 15,515 | 2,822 | 12/14/23 |
Mulham David Mulham | CHIEF SALES OFFICER CHIEF SALES OFFICER | Aug 15 | Sell | 65.3389 | 2,159 | 141,067 | 5,448 | 08/16/23 |
Mulham David Mulham | CHIEF SALES OFFICER CHIEF SALES OFFICER | Aug 11 | Sell | 66.2825 | 1,080 | 71,585 | 7,607 | 08/15/23 |
FULLER GILBERT A | Director Director | Jul 31 | Sell | 65.0120 | 226 | 14,693 | 265 | 08/01/23 |
Mulham David Mulham | CHIEF SALES OFFICER CHIEF SALES OFFICER | Jul 31 | Sell | 65 | 3,354 | 218,010 | 8,687 | 08/01/23 |
Jones Paul A. | CHIEF PEOPLE OFFICER CHIEF PEOPLE OFFICER | Jul 28 | Sell | 65 | 3,682 | 239,330 | 3,353 | 07/31/23 |
Ding Xia | Director Director | Jul 27 | Sell | 65.5994 | 606 | 39,753 | 1,421 | 07/28/23 |
Mulham David Mulham | CHIEF SALES OFFICER CHIEF SALES OFFICER | Jun 15 | Sell | 61 | 1,557 | 94,977 | 12,041 | 06/16/23 |
Macuga Daniel A. | CHIEF COMMUNICATIONS.. CHIEF COMMUNICATIONS OFFICER | Jun 14 | Sell | 62.88 | 2,234 | 140,474 | 778 | 06/15/23 |
Mulham David Mulham | CHIEF SALES OFFICER CHIEF SALES OFFICER | Apr 28 | Sell | 67.3984 | 1,138 | 76,699 | 13,598 | 04/28/23 |
Nixon J Scott | Director Director | Apr 28 | Sell | 67.2977 | 2,450 | 164,879 | 924 | 04/28/23 |
FULLER GILBERT A | Director Director | Apr 28 | Sell | 67.0504 | 404 | 27,088 | 04/28/23 | |
Guest Kevin | CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER | Mar 07 | Sell | 60.1541 | 5,297 | 318,636 | 4,058 | 03/08/23 |
Guest Kevin | CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER | Feb 22 | Sell | 60.52 | 13,288 | 804,190 | 9,355 | 02/23/23 |
Macuga Daniel A. | CHIEF COMMUNICATIONS.. CHIEF COMMUNICATIONS OFFICER | Feb 17 | Sell | 62.22 | 3,012 | 187,407 | 3,012 | 02/21/23 |
FULLER GILBERT A | Director Director | Feb 16 | Sell | 61.85 | 404 | 24,987 | 02/17/23 | |
Foukas Joshua | CHIEF LEGAL OFFICER CHIEF LEGAL OFFICER | Feb 16 | Sell | 61.01 | 3,771 | 230,069 | 02/17/23 | |
Neidig Brent | CO & MAN. DIR. OF CH.. CO & MAN. DIR. OF CHINA | Feb 09 | Sell | 61.8934 | 1,872 | 115,864 | 2,435 | 02/10/23 |
Macuga Daniel A. | CHIEF COMMUNICATIONS.. CHIEF COMMUNICATIONS OFFICER | Dec 05 | Sell | 53.9176 | 1,474 | 79,475 | 2,234 | 12/06/22 |
FULLER GILBERT A | Director Director | Nov 08 | Sell | 52.11 | 404 | 21,052 | 11/09/22 | |
IIEKKING G DOUG | CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER | Aug 01 | Sell | 70.5059 | 2,924 | 206,159 | 08/23/22 | |
Foukas Joshua | CHIEF LEGAL OFFICER CHIEF LEGAL OFFICER | Aug 16 | Sell | 72.04 | 248 | 17,866 | 08/17/22 | |
Jones Paul A. | CHIEF PEOPLE OFFICER CHIEF PEOPLE OFFICER | Aug 15 | Sell | 70 | 5,029 | 352,030 | 3,682 | 08/17/22 |
FULLER GILBERT A | Director Director | Jul 29 | Sell | 70 | 404 | 28,280 | 08/01/22 | |
Neidig Brent | CO & MAN. DIR. OF CH.. CO & MAN. DIR. OF CHINA | Jun 16 | Sell | 70.93 | 1,400 | 99,302 | 1,406 | 06/17/22 |
FULLER GILBERT A | Director Director | May 20 | Sell | 68.25 | 312 | 21,294 | 05/23/22 | |
Foukas Joshua | CHIEF LEGAL OFFICER CHIEF LEGAL OFFICER | Mar 02 | Sell | 89.9283 | 3,303 | 297,033 | 03/04/22 | |
Noot Walter | Chief Operating Offi.. Chief Operating Officer | Feb 14 | Sell | 91.02 | 3,849 | 350,336 | 02/16/22 | |
FULLER GILBERT A | Director Director | Feb 15 | Sell | 89.6224 | 312 | 27,962 | 02/16/22 | |
SINNOTT ROBERT A | Chief Scientific Off.. Chief Scientific Officer | Aug 18 | Sell | 94.52 | 9,140 | 863,913 | 08/18/21 | |
SINNOTT ROBERT A | Chief Scientific Off.. Chief Scientific Officer | Aug 18 | Option | 65.48 | 9,140 | 598,487 | 7,492 | 08/18/21 |
Noot Walter | Chief Operating Offi.. Chief Operating Officer | Feb 25 | Option | 62.2 | 3,571 | 222,116 | 3,571 | 02/25/21 |
Noot Walter | Chief Operating Offi.. Chief Operating Officer | Feb 25 | Sell | 94.51 | 3,571 | 337,495 | 02/25/21 | |
Guest Kevin | C.E.O. C.E.O. | Feb 25 | Option | 63.02 | 3,669 | 231,220 | 13,065 | 02/25/21 |
Guest Kevin | C.E.O. C.E.O. | Feb 25 | Sell | 95 | 13,065 | 1,241,175 | 02/25/21 | |
Guest Kevin | C.E.O. C.E.O. | Feb 16 | Option | 63.02 | 1,854 | 116,839 | 11,250 | 02/16/21 |
Guest Kevin | C.E.O. C.E.O. | Feb 16 | Sell | 95.35 | 1,854 | 176,779 | 9,396 | 02/16/21 |
Foukas Joshua | Chief Legal Officer Chief Legal Officer | Oct 27 | Sell | 84.06 | 197 | 16,560 | 10/27/20 | |
Noot Walter | Chief Operating Offi.. Chief Operating Officer | Oct 27 | Sell | 84.74 | 351 | 29,744 | 10/27/20 | |
Neidig Brent | Chief Officer & MD o.. Chief Officer & MD of China | Oct 27 | Sell | 84.81 | 175 | 14,842 | 10/27/20 | |
SINNOTT ROBERT A | Chief Scientific Off.. Chief Scientific Officer | Oct 26 | Option | 65.48 | 6,043 | 395,696 | 6,043 | 10/26/20 |
SINNOTT ROBERT A | Chief Scientific Off.. Chief Scientific Officer | Oct 26 | Sell | 83.37 | 6,361 | 530,317 | 10/26/20 | |
Peng Feng | Director Director | Oct 23 | Sell | 82.81 | 330 | 27,327 | 1,181 | 10/23/20 |
AUCIAUX ROBERT | Director Director | Oct 23 | Sell | 85.29 | 989 | 84,352 | 426 | 10/23/20 |